These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8934574)

  • 1. High mobility group protein I(Y) is required for function and for c-Rel binding to CD28 response elements within the GM-CSF and IL-2 promoters.
    Himes SR; Coles LS; Reeves R; Shannon MF
    Immunity; 1996 Nov; 5(5):479-89. PubMed ID: 8934574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RelA is a potent transcriptional activator of the CD28 response element within the interleukin 2 promoter.
    Lai JH; Horvath G; Subleski J; Bruder J; Ghosh P; Tan TH
    Mol Cell Biol; 1995 Aug; 15(8):4260-71. PubMed ID: 7623820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear factor of activated T cells contributes to the function of the CD28 response region of the granulocyte macrophage-colony stimulating factor promoter.
    Shang C; Attema J; Cakouros D; Cockerill PN; Shannon MF
    Int Immunol; 1999 Dec; 11(12):1945-56. PubMed ID: 10590260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the interleukin-2 CD28-responsive element by NF-ATp and various NF-kappaB/Rel transcription factors.
    Maggirwar SB; Harhaj EW; Sun SC
    Mol Cell Biol; 1997 May; 17(5):2605-14. PubMed ID: 9111330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal and subunit-specific modulations of the Rel/NF-kappaB transcription factors through CD28 costimulation.
    Kahn-Perlès B; Lipcey C; Lécine P; Olive D; Imbert J
    J Biol Chem; 1997 Aug; 272(35):21774-83. PubMed ID: 9268307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of high-mobility group I(Y) proteins in expression of IL-2 and T cell proliferation.
    Himes SR; Reeves R; Attema J; Nissen M; Li Y; Shannon MF
    J Immunol; 2000 Mar; 164(6):3157-68. PubMed ID: 10706706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional disparity of distinct CD28 response elements toward mitogenic responses.
    Civil A; Rensink I; Aarden LA; Verweij CL
    J Biol Chem; 1999 Nov; 274(48):34369-74. PubMed ID: 10567414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 Tat inhibits IL-2 gene transcription through qualitative and quantitative alterations of the cooperative Rel/AP1 complex bound to the CD28RE/AP1 composite element of the IL-2 promoter.
    González E; Punzón C; González M; Fresno M
    J Immunol; 2001 Apr; 166(7):4560-9. PubMed ID: 11254713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coordinate transactivation of the interleukin-2 CD28 response element by c-Rel and ATF-1/CREB2.
    Butscher WG; Powers C; Olive M; Vinson C; Gardner K
    J Biol Chem; 1998 Jan; 273(1):552-60. PubMed ID: 9417115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of Rel, Fos, and Jun proteins in binding activity to the IL-2 promoter CD28 response element/AP-1 sequence in human T cells.
    McGuire KL; Iacobelli M
    J Immunol; 1997 Aug; 159(3):1319-27. PubMed ID: 9233628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-kappaB-inducing kinase is involved in the activation of the CD28 responsive element through phosphorylation of c-Rel and regulation of its transactivating activity.
    Sánchez-Valdepeñas C; Martín AG; Ramakrishnan P; Wallach D; Fresno M
    J Immunol; 2006 Apr; 176(8):4666-74. PubMed ID: 16585559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depletion of c-Rel from cytokine gene promoters is required for chromatin reassembly and termination of gene responses to T cell activation.
    Poke FS; Upcher WR; Sprod OR; Young A; Brettingham-Moore KH; Holloway AF
    PLoS One; 2012; 7(7):e41734. PubMed ID: 22860011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism responsible for T-cell antigen receptor- and CD28- or interleukin 1 (IL-1) receptor-initiated regulation of IL-2 gene expression by NF-kappaB.
    Kalli K; Huntoon C; Bell M; McKean DJ
    Mol Cell Biol; 1998 Jun; 18(6):3140-8. PubMed ID: 9584155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GM-CSF and IL-2 share common control mechanisms in response to costimulatory signals in T cells.
    Shannon MF; Himes SR; Coles LS
    J Leukoc Biol; 1995 May; 57(5):767-73. PubMed ID: 7759956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TCR/CD28-stimulated actin dynamics are required for NFAT1-mediated transcription of c-rel leading to CD28 response element activation.
    Nolz JC; Fernandez-Zapico ME; Billadeau DD
    J Immunol; 2007 Jul; 179(2):1104-12. PubMed ID: 17617603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms underlying differential contribution of CD28 versus non-CD28 costimulatory molecules to IL-2 promoter activation.
    Zhou XY; Yashiro-Ohtani Y; Nakahira M; Park WR; Abe R; Hamaoka T; Naramura M; Gu H; Fujiwara H
    J Immunol; 2002 Apr; 168(8):3847-54. PubMed ID: 11937538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rel-deficient T cells exhibit defects in production of interleukin 3 and granulocyte-macrophage colony-stimulating factor.
    Gerondakis S; Strasser A; Metcalf D; Grigoriadis G; Scheerlinck JY; Grumont RJ
    Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3405-9. PubMed ID: 8622948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a CD28 response element in the CD40 ligand promoter.
    Parra E; Mustelin T; Dohlsten M; Mercola D
    J Immunol; 2001 Feb; 166(4):2437-43. PubMed ID: 11160303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Rel is required for chromatin remodeling across the IL-2 gene promoter.
    Rao S; Gerondakis S; Woltring D; Shannon MF
    J Immunol; 2003 Apr; 170(7):3724-31. PubMed ID: 12646638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD28 mediates transcriptional upregulation of the interleukin-2 (IL-2) promoter through a composite element containing the CD28RE and NF-IL-2B AP-1 sites.
    Shapiro VS; Truitt KE; Imboden JB; Weiss A
    Mol Cell Biol; 1997 Jul; 17(7):4051-8. PubMed ID: 9199340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.